Results 21 to 30 of about 578,139 (333)

Comparison of fusion methods for thermo-visual surveillance tracking [PDF]

, 2006
In this paper, we evaluate the appearance tracking performance of multiple fusion schemes that combine information from standard CCTV and thermal infrared spectrum video for the tracking of surveillance objects, such as people, faces, bicycles and ...
Cooke, Eddie, O'Connor, Noel E., Smeaton, Alan F., Ó Conaire, Ciarán   +3 more
core   +2 more sources

SAFETY OF MILK AND MEAT PRODUCTS IN THE RUSSIAN FEDERATION IN DYNAMICS: RESULTS OF SANITARY-EPIDEMIOLOGICAL CONTROL (2013-2022)

Siberian Journal of Life Sciences and Agriculture, 2023
Background. The study addresses an extremely important issue, namely quality and safety of meat and milk products that are consumed daily by majority of the population in the Russian Federation. Aim. To investigate safety of animal food products (meat
Irina V. May, Nadezhda V. Nikiforova
doaj   +1 more source

Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital

Journal of Research in Pharmacy Practice, 2019
Objective: Drug therapeutic failures (TFs) are included in pharmacovigilance reporting, as some authors consider them a type of adverse drug reaction.
Jair Antonio Ruiz-Garzon, Camilo Andrés Rojas-Velandia, Carlos-Alberto Calderon-Ospina   +2 more
doaj   +1 more source

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

Microorganisms, 2021
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13).
Maria Deloria Knoll, Julia C. Bennett, Maria Garcia Quesada, Eunice W. Kagucia, Meagan E. Peterson, Daniel R. Feikin, Adam L. Cohen, Marissa K. Hetrich, Yangyupei Yang, Jenna N. Sinkevitch, Krow Ampofo, Laurie Aukes, Sabrina Bacci, Godfrey Bigogo, Maria-Cristina C. Brandileone, Michael G. Bruce, Romina Camilli, Jesús Castilla, Guanhao Chan, Grettel Chanto Chacón, Pilar Ciruela, Heather Cook, Mary Corcoran, Ron Dagan, Kostas Danis, Sara de Miguel, Philippe De Wals, Stefanie Desmet, Yvonne Galloway, Theano Georgakopoulou, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, James D. Kellner, Jackie Kleynhans, Mirjam J. Knol, Jana Kozakova, Karl Gústaf Kristinsson, Shamez N. Ladhani, Claudia S. Lara, Maria Eugenia León, Tiia Lepp, Grant A. Mackenzie, Lucia Mad’arová, Allison McGeer, Tuya Mungun, Jason M. Mwenda, J. Pekka Nuorti, Néhémie Nzoyikorera, Kazunori Oishi, Lucia Helena De Oliveira, Metka Paragi, Tamara Pilishvili, Rodrigo Puentes, Eric Rafai, Samir K. Saha, Larisa Savrasova, Camelia Savulescu, J. Anthony Scott, Kevin J. Scott, Fatima Serhan, Lena Petrova Setchanova, Nadja Sinkovec Zorko, Anna Skoczyńska, Todd D. Swarthout, Palle Valentiner-Branth, Mark van der Linden, Didrik F. Vestrheim, Anne von Gottberg, Inci Yildirim, Kyla Hayford, the PSERENADE Team   +72 more
doaj   +1 more source

The Case for Product-Specific Surveillance

American Journal of Public Health, 2020
There is no abstract associated with this publication.
openaire   +3 more sources

Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework

npj Digital Medicine, 2021
The Sentinel System is a major component of the United States Food and Drug Administration’s (FDA) approach to active medical product safety surveillance.
Rishi J. Desai, Michael E. Matheny, Kevin Johnson, Keith Marsolo, Lesley H. Curtis, Jennifer C. Nelson, Patrick J. Heagerty, Judith Maro, Jeffery Brown, Sengwee Toh, Michael Nguyen, Robert Ball, Gerald Dal Pan, Shirley V. Wang, Joshua J. Gagne, Sebastian Schneeweiss   +15 more
doaj   +1 more source

Influenza Vaccines: From Surveillance Through Production to Protection [PDF]

Mayo Clinic Proceedings, 2010
Influenza is an important contributor to population and individual morbidity and mortality. The current influenza pandemic with novel H1N1 has highlighted the need for health care professionals to better understand the processes involved in creating influenza vaccines, both for pandemic as well as for seasonal influenza.
Pritish K, Tosh, Robert M, Jacobson, Gregory A, Poland   +2 more
openaire   +2 more sources

Postmarketing surveillance Is not used to promote products [PDF]

BMJ, 1994
EDITOR, - Simon Voss and Fiona Harris's concerns about postmarketing surveillance need to be challenged.1 Without producing any evidence the authors imply deceit by pharmaceutical companies in three ways: firstly, by using “so called” independent research companies that do not acknowledge their link with the pharmaceutical companies; secondly, by using
M Vandenburg, W H Inman
openaire   +2 more sources

cfr and fexA genes in methicillin-resistant Staphylococcus aureus from humans and livestock in the Netherlands

Communications Medicine, 2022
Schouls et al. characterize antimicrobial resistance genes in MRSA isolates from humans and livestock in the Netherlands. The multidrug resistance gene cfr and the phenicol resistance gene fexA are identified in both types of samples, including in ...
Leo M. Schouls, Kees Veldman, Michael S. M. Brouwer, Cindy Dierikx, Sandra Witteveen, Marga van Santen-Verheuvel, Antoni P. A. Hendrickx, Fabian Landman, Paul Hengeveld, Bart Wullings, Michel Rapallini, Ben Wit, Engeline van Duijkeren, the Dutch MRSA surveillance study group   +13 more
doaj   +1 more source

Postmarketing Surveillance for "Modified-Risk" Tobacco Products [PDF]

Nicotine & Tobacco Research, 2011
The U.S. Food and Drug Administration (FDA) acquired authority to regulate tobacco products in 2009. This authority will provide a structured process for manufacturers to introduce products that may have "modified-risk" for morbidity or mortality relative to traditional tobacco products, with postmarketing surveillance and studies a condition of ...
openaire   +2 more sources